AstraZeneca, Pfizer begin accelerated review for COVID-19 vaccines in UK

More posts on drug store: Ascension launches drug store services service Ascension Rx6 current pharma industry exec movesFDA lists vital medications, countermeasures and pharmaceutical active ingredients.

Katie Adams –
Monday, November 2nd, 2020
Print|Email.

The U.K. is speeding up the approval procedure for the COVID-19 vaccines being established by AstraZeneca and Pfizer, Newsy reported Nov. 1.

The countrys health regulator began a sped up review for the COVID-19 vaccine candidate AstraZenec is establishing with the University of Oxford. Regulators are conducting a “rolling review,” meaning they will analyze scientific trial information in real time while preparing with the drugmaker about production and distribution.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.

The U.K. is also speeding up the evaluation process for Pfizers COVID-19 vaccine candidate, Bloomberg reported Oct. 31.